Pharma DM to Top $1 Bil., DMA Says

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK Pharmaceutical companies will spend more than $1 billion on direct marketing in 2008 and see revenue of $10.6 billion, according to a new report from the Direct Marketing Association.

And those figures will not slow down anytime soon. Over the next five years, direct marketing-driven sales are projected to compound 9.4 percent annually, topping $15 billion in 2012.

“The American pharmaceutical industry employs direct marketing extensively and successfully,” DMA research manager Michelle Tiletnick said in a statement.

Marketing dollars also will continue to be spent in other key areas, according to Direct Marketing Facts and Figures in the Pharmaceutical Industry.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in